Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

RATIONALE: There is an unmet need in the treatment of schizophrenia for effective medications with fewer adverse effects. OBJECTIVE: This study aims to evaluate the efficacy and safety of lurasidone, an atypical antipsychotic, for the treatment of schizophrenia. METHODS: Patients with an acute exace...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogasa, Masaaki, Kimura, Tatsuya, Nakamura, Mitsutaka, Guarino, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546299/
https://www.ncbi.nlm.nih.gov/pubmed/22903391
http://dx.doi.org/10.1007/s00213-012-2838-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546299/
https://www.ncbi.nlm.nih.gov/pubmed/22903391
http://dx.doi.org/10.1007/s00213-012-2838-2

Ejemplares similares